Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
481 studies found for:    Vaginal Diseases: Clinical Trials
Show Display Options
RSS Create an RSS feed from your search for:
Vaginal Diseases: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide
Conditions: HIV Infections;   Chlamydia Trachomatis;   Neisseria Gonorrhoeae;   Trichomonas Vaginitis;   Syphilis;   Herpes Simplex
Intervention: Drug: Carraguard  (PC-515)
2 Completed Allogenic Stem Cells Derived From Lipoaspirates for the Treatment of Recto-vaginal Fistulas Associated to Crohn`s Disease (ALOREVA)
Conditions: Rectovaginal Fistula;   Crohn Disease
Intervention: Drug: Expanded allogenic adipose-derived adult stem cells
3 Completed
Has Results
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 30 mg;   Drug: Ospemifene 60 mg;   Drug: Placebo;   Drug: Nonhormonal vaginal lubricant
4 Completed
Has Results
A Clinical Study to Evaluate the Safety of Ospemifene
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 60 mg;   Drug: Placebo
5 Completed
Has Results
A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Placebo;   Drug: Ospemifene 5 mg;   Drug: Ospemifene 15 mg;   Drug: Ospemifene 30 mg
6 Completed Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Intervention: Drug: estradiol, 10 mcg
7 Completed
Has Results
Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 60 mg;   Drug: Placebo;   Drug: Non-hormonal vaginal lubricant
8 Completed
Has Results
Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus
Conditions: Atrophy;   Vaginal Diseases
Intervention: Drug: Ospemifene
9 Completed
Has Results
Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene (Dose 1);   Drug: Ospemifene (Dose 2);   Drug: Placebo
10 Completed Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission
Conditions: HIV Infections;   Chlamydia Trachomatis;   Neisseria Gonorrhoeae;   Trichomonas Vaginitis;   Syphilis
Intervention: Drug: Carraguard (PC-515)
11 Completed Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis
Condition: Pregnancy
Interventions: Drug: Clindamycin;   Drug: Placebo
12 Unknown  Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community
Conditions: HIV Infections;   Sexually Transmitted Diseases;   Papillomavirus Infections;   Genital Herpes;   Gonorrhea;   Chlamydia Infections;   Syphilis;   Bacterial Vaginosis
Intervention: Procedure: Male circumcision
13 Recruiting Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis
Condition: Candidiasis, Vulvovaginal
Interventions: Drug: Lcr Regenerans;   Drug: Placebo
14 Completed
Has Results
Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial
Condition: Bacterial Vaginosis
Interventions: Drug: Vaginal acidifying gel (RepHresh);   Drug: Metronidazole control
15 Recruiting A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis
Condition: Atrophic Vaginitis
Interventions: Drug: Estradiol Vaginal Cream, 0.01%;   Drug: Estrace® 0.01% cream;   Drug: Placebo Vaginal Cream
16 Completed Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence
Condition: Bacterial Vaginosis
Interventions: Other: hygienic information plus 62% ethyl alcohol in emollient gel;   Other: hygienic information
17 Unknown  Hyaluronic Acid and Vaginal Distress
Condition: Vaginal Disease
Intervention: Other: hyaluronic acid pill
18 Completed Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
Conditions: Pelvic Inflammatory Disease;   Chlamydia Infections
Intervention: Procedure: Screening for chlamydia using self-taken vaginal swabs
19 Terminated
Has Results
A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis
Condition: Atrophic Vaginitis
Interventions: Drug: Estriol;   Drug: Estradiol valerate;   Drug: Vanicream Lite
20 Terminated Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity
Conditions: Bacterial Vaginosis;   Premature Birth;   Sepsis;   Periventricular Leukomalacia;   Bronchopulmonary Dysplasia
Intervention: Drug: Lactobacillus rhamnosus GR1 and Lactobacillus reuteri RC-14

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years